One year. That's how long Illumina CEO Jay Flatley has to prove he can increase his company's value beyond Roche's $6.7 billion takeover bid, Maxim Group analyst Bryan Brokmeier tells Bloomberg.
Already have a GenomeWeb or 360Dx account?Login Now.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.